Principales desenlaces clínicos en lactantes con insuficiencia respiratoria aguda tratados con cánula nasal de alto flujo

Abstract

The High Flow Nasal Cannula (HFNC) is a non-invasive ventilatory modality that is increasingly used in the pediatric population in which benefits are described on oxygenation, ventilation and comfort of the patient through mechanisms of action that have been studied and described in the medical literature, however there is still little evidence regarding the efficacy and safety of the high-flow nasal cannula, so through this study we will generate scientific information and know what the main outcomes of infants are. One month and up to 23 months of age were treated with acute respiratory failure with high flow nasal cannula in the pediatric intensive care unit of the Colsubsidio Children's Clinic between 2016 -2017.